1.54
0.65%
-0.01
시간 외 거래:
1.53
-0.01
-0.65%
전일 마감가:
$1.55
열려 있는:
$1.56
하루 거래량:
7,863
Relative Volume:
0.57
시가총액:
$17.99M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
0.343
EPS:
4.49
순현금흐름:
$-9.76M
1주 성능:
-1.91%
1개월 성능:
-6.24%
6개월 성능:
-18.09%
1년 성능:
-30.32%
Therapeuticsmd Inc Stock (TXMD) Company Profile
명칭
Therapeuticsmd Inc
전화
561-961-1900
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2020-08-07 | 다운그레이드 | Jefferies | Hold → Underperform |
2020-05-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2019-12-02 | 개시 | Guggenheim | Buy |
2019-10-17 | 개시 | H.C. Wainwright | Buy |
2019-04-30 | 재개 | Noble Capital Markets | Outperform |
2018-06-15 | 개시 | JP Morgan | Overweight |
2017-09-08 | 개시 | Morgan Stanley | Equal-Weight |
2017-07-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
2017-05-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2016-11-22 | 재개 | Jefferies | Buy |
2016-11-22 | 개시 | Oppenheimer | Outperform |
2016-11-07 | 재개 | Guggenheim | Buy |
2016-04-04 | 개시 | Goldman | Buy |
2015-12-08 | 재확인 | Jefferies | Buy |
2015-12-08 | 재확인 | Stifel | Buy |
2015-09-21 | 재확인 | Jefferies | Buy |
2015-06-09 | 개시 | Guggenheim | Buy |
2014-07-08 | 개시 | FBR Capital | Outperform |
2014-04-17 | 재확인 | Noble Financial | Buy |
2014-01-28 | 재확인 | Noble Financial | Buy |
모두보기
Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
TherapeuticsMD Inc. stock remains steady Thursday, still outperforms market - MarketWatch
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock rises Tuesday, still underperforms market - MarketWatch
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock rises Thursday, still underperforms market - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
TherapeuticsMD Inc. stock remains steady Thursday, underperforms market - MarketWatch
TherapeuticsMD Inc. stock remains steady Friday, underperforms market - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Sexual Wellness Market to Witness 4.7% CAGR by 2031 | SkyQuest Technology - Benzinga
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com - Defense World
TherapeuticsMD announces revised shareholder proposal deadline By Investing.com - Investing.com Australia
TherapeuticsMD announces revised shareholder proposal deadline - Investing.com India
Tourmaline Bio (NASDAQ:TRML) Shares Up 3.9% - Defense World
This company generates no revenue and its market cap is over $20 billion. Here's why that valuation - The Bharat Express News
Commonwealth Equity Services LLC Has $979,000 Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
WINTON GROUP Ltd Buys New Shares in Tactile Systems Technology, Inc. (NASDAQ:TCMD) - MarketBeat
TransMedics Stock: Take Profits While The Valuation Is Sky High (NASDAQ:TMDX) - Seeking Alpha
Somite’s SMT-M01 awarded US orphan drug designation for Duchenne muscular dystrophy - BioWorld Online
Transmedics Group Inc (TMDX) deserves deeper analysis - US Post News
This is why everyone is talking about Summit TherapeuticsTHE BHARAT EXPRESS NEWS - The Bharat Express News
Here's Why Everyone's Talking About Summit Therapeutics - The Motley Fool
An analyst sees good growth prospects for Transmedics Group Inc (TMDX) - SETE News
Implant maker Tenon Medical nearly triples its market capitalization in two days - Kursiv Media
TD Asset Management Inc Invests $2.08 Million in Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World
Summit lifts Instil, BioNTech on Merck beating data (NASDAQ:SMMT) - Seeking Alpha
Therapeuticsmd Inc (TXMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Therapeuticsmd Inc 주식 (TXMD) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Collins Cooper C. | Director |
Aug 21 '24 |
Buy |
1.70 |
1,200 |
2,039 |
47,922 |
Walker Marlan D | Chief Executive Officer |
Dec 05 '23 |
Option Exercise |
0.00 |
70,000 |
0 |
81,615 |
Walker Marlan D | Chief Executive Officer |
Dec 06 '23 |
Sale |
2.31 |
14,500 |
33,496 |
67,115 |
Walker Marlan D | Chief Executive Officer |
Dec 07 '23 |
Sale |
2.24 |
4,550 |
10,187 |
62,565 |
자본화:
|
볼륨(24시간):